Pharmaceutical and Food Coating and Dispersing Machine, Coating Equipment, Ultra-Fine Dispersion Machine
Release time:
2026-03-23 09:12
Source:
The core value of the coating-modification machine lies in the performance enhancement of materials after processing. Food- and pharmaceutical-grade materials treated with this equipment exhibit comprehensive improvements over their unmodified counterparts in terms of safety, stability, functionality, and practicality. Not only does it address the inherent limitations of conventional materials, but it also provides critical support for the innovative research and development of food and pharmaceutical products.

In the food industry, the advantages of modified materials are primarily evident in four key areas: first, more complete retention of nutrients, which extends the shelf life of heat-sensitive and oxidation-prone nutrients such as vitamins and probiotics. First, the nutritional value is preserved by 2–3 times, while minimizing nutrient loss during processing; second, the material exhibits significantly improved performance: the modified powder demonstrates more than a 30% enhancement in flowability, with no agglomeration or caking, resulting in rapid dissolution upon reconstitution, no layering, and a smoother mouthfeel. At the same time, moisture-proofing and anti-sticking properties are effectively addressed, facilitating storage and processing; third, it is safer for consumption: coating modification can reduce the off-flavors and irritancy of food additives, decrease their degradation during processing, and prevent direct contact between nutrients and the external environment, thereby lowering contamination risks and aligning with consumers’ demand for healthier foods; fourth, it delivers higher added value: ordinary powders, after modification, can be upgraded from basic raw materials into specialized functional ingredients, suitable for the production of high-end foods and health supplements, helping companies elevate product quality and strengthen market competitiveness. For example, probiotic powders that have undergone coating modification can be stored at room temperature and, once ingested, achieve targeted, sustained release in the intestinal tract, substantially enhancing probiotic viability and absorption efficiency—making them ideal for premium products such as health supplements and infant formula.

In the pharmaceutical field, the advantages of modified materials are directly linked to drug efficacy and medication safety, with the core benefits manifesting in five key aspects: first, there is a significant enhancement in drug efficacy; for poorly soluble drugs, coating modification can substantially improve their solubility. First, bioavailability is increased by more than 50%, making drugs easier for the body to absorb; moreover, sustained- and controlled-release formulations can prolong drug efficacy, reduce dosing frequency, and enhance the patient’s medication experience. Second, stability is significantly enhanced: drugs that are prone to degradation or inactivation—such as biologics and antibiotics—can be protected from environmental factors like light and moisture through coating, thereby preventing degradation, maintaining consistent potency throughout the shelf life, and reducing medication risks. Third, safety is improved: coating-based modification can reduce gastrointestinal irritation and minimize toxic side effects, while also enhancing the biocompatibility of medical materials, lowering the incidence of immune rejection, and making them suitable for orthopedic implants and medical dressings. Fourth, processing performance is superior: coated drug powders exhibit improved flowability and compressibility, facilitating downstream operations such as tableting and capsule filling, reducing material loss during processing, and boosting production efficiency. Fifth, application scenarios are expanded: modified drug carrier materials enable targeted drug delivery, allowing precise localization at the site of disease and enhancing therapeutic outcomes; they can also be used in the development of novel dosage forms—such as microcapsules and microspheres—thereby broadening the range of pharmaceutical products and driving innovation in the pharmaceutical industry.
Related News